The Patent Finder

Induction Medium and Methods for Stem Cell Culture and Therapy

Sanbio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 14/504,399, filed Oct 1, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,321,994Induction Medium and Methods for Stem Cell Culture and Therapy
In force
 · Medium confidence
Sanbio, Inc.In force
Medium confidence
US 10,273,449Induction Medium and Methods for Stem Cell Culture and Therapy
In force
 · Medium confidence
Sanbio, Inc.In force
Medium confidence
US 11,046,929Induction Medium and Methods for Stem Cell Culture and Therapy
In force
 · High confidence
Sanbio, Inc.In force
High confidence
Application 14/504,399Induction Medium & Methods for Stem Cell Culture & Therapy
Abandoned
Abandoned Oct 16, 2017
Sanbio, Inc.AbandonedAbandoned Oct 16, 2017
Application 15/072,943Induction Medium and Methods for Stem Cell Culture and Therapy
Abandoned
Abandoned Apr 13, 2018
Sanbio, Inc.AbandonedAbandoned Apr 13, 2018
Application 17/096,559Induction Medium and Methods for Stem Cell Culture and Therapy
Abandoned
Abandoned May 11, 2026
Sanbio, Inc.AbandonedAbandoned May 11, 2026
Application 19/665,737Induction Medium and Methods for Stem Cell Culture and Therapy
Pending
Not granted
Sanbio, Inc.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Sanbio, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited